Medivolve Inc.
Medivolve Inc. (4NC.F) Stock Competitors & Peer Comparison
See (4NC.F) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4NC.F | €0.00 | +0.00% | 0 | 0.07 | €0.05 | N/A |
| TN8.DE | €446.30 | -0.53% | 166B | 29.44 | €15.18 | +0.33% |
| DAP.DE | €165.20 | -0.54% | 116.3B | 38.48 | €4.27 | +0.37% |
| ILU.DE | €114.78 | +1.90% | 17.2B | 24.28 | €4.64 | N/A |
| QIA.DE | €34.81 | -1.54% | 7.2B | 20.20 | €1.73 | +6.51% |
| SYAB.DE | €11.06 | -0.18% | 2.4B | 27.65 | €0.40 | N/A |
| NN6.DE | €1.53 | +2.69% | 19.6M | -11.07 | -€0.14 | N/A |
| ECX.F | €0.92 | +0.00% | 806.8K | -0.29 | -€3.15 | N/A |
| ECX.DE | €0.70 | -11.17% | 612.6K | -0.04 | -€19.55 | N/A |
Stock Comparison
4NC.F vs TN8.DE Comparison April 2026
4NC.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4NC.F stands at 0. In comparison, TN8.DE has a market cap of 166B. Regarding current trading prices, 4NC.F is priced at €0.00, while TN8.DE trades at €446.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4NC.F currently has a P/E ratio of 0.07, whereas TN8.DE's P/E ratio is 29.44. In terms of profitability, 4NC.F's ROE is N/A, compared to TN8.DE's ROE of +0.13%. Regarding short-term risk, 4NC.F is more volatile compared to TN8.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 4NC.F.Check TN8.DE's competition here